Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predicting drug-drug and drug-gene interactions in a community pharmacy population.

The American journal of managed care - 1 Nov 2022

Dowd Daniel, Williams Gabriela, VanDorn Daniel, Clarke Stephen, Krause David S, Botbyl Jeffrey, Saklad Stephen R

Abstract excerpt

OBJECTIVES: Drug-drug interactions (DDIs) are among the most common causes of adverse drug reactions and are further complicated by genetic variants of drug-metabolizing enzymes. The aim of this study is to quantify and describe potential DDIs, drug-gene interactions (DGIs), and drug-drug-gene interactions (DDGIs) in a community-based population. STUDY DESIGN: This was an analysis of deidentified retail pharmacy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Interactions
Share to Drug-Related Side Effects and Adverse Reactions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Associations and Epidemiology

Share to Genotype

Share to Pharmacogenetics and Drug Metabolism

Source

Identifiers

PMID: 36374614
DOI: 10.37765/ajmc.2022.89259

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predicting drug-drug and drug-gene interactions in a community pharmacy population.PMID 36374614Read ↗

Defining the Opportunity for Pharmacogenetic Intervention in Primary CareSemantic proximity Read ↗

How common are drug and gene interactions? Prevalence in a sample of 1143 patients with CYP2C9, CYP2C19 and CYP2D6 genotyping.Semantic proximity Read ↗

Genetic Risk Factors for Adverse Drug ReactionsSemantic proximity Read ↗

Pharmacogenetics and adverse drug reactions.Semantic proximity Read ↗

Digging up the human genome: current progress in deciphering adverse drug reactions.Semantic proximity Read ↗

The role of pharmacogenomics in adverse drug reactionsSemantic proximity Read ↗

Estimating the prevalence of potential and actionable drug-gene interactions in Irish primary care: a cross-sectional studySemantic proximity Read ↗

Potential Impact of Pharmacogenomic Single Nucleotide Variants in a Rural Caucasian Population.Semantic proximity Read ↗

CYP2D6 drug-gene and drug-drug-gene interactions among patients prescribed pharmacogenetically actionable opioidsSemantic proximity Read ↗

What Will Be the Role of Pharmacogenetics in Evaluating Drug Safety and Minimising Adverse Effects?Semantic proximity Read ↗

Dosing recommendations for pharmacogenetic interactions related to drug metabolism.Semantic proximity Read ↗

CLINICAL OPPORTUNITIES FOR GERMLINE PHARMACOGENETICS AND MANAGEMENT OF DRUG-DRUG INTERACTIONS IN PATIENTS WITH ADVANCED SOLID CANCERSSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.